|
Content is displayed in order of publication date, beginning with the most recent issue. To search for content by title or author, use the Search feature, above.
Examining The EvidenceDo aromatase inhibitors extend disease-free survival after tamoxifen therapy in breast cancer survivors?
Andrew M. Kaunitz, MD
Full text | PDF Does self-administered misoprostol prime the cervix for hysteroscopy?
Joan M.G. Crane, MD, MSc
Full text | PDF Can intrauterine growth restriction be present in the first trimester?
John M. Thorp Jr, MD
Full text | PDF Does a short course of nitrofurantoin cure acute uncomplicated cystitis?
Sebastian Faro, MD, PhD
Full text | PDF Does a PICC line facilitate treatment of hyperemesis gravidarum?
T. Murphy Goodwin, MD
Full text | PDF Do the risks of hormone therapy persist after discontinuation?
Andrew M. Kaunitz, MD
Full text | PDF Does treating asymptomatic bacterial vaginosis reduce preterm delivery?
Hyagriv N. Simhan, MD, MSCR
Full text | PDF Do women who have CIN 3 face an elevated risk of Ca after treatment?
Charles J. Dunton, MD
Full text | PDF Does hysterectomy raise the risk of stress-incontinence surgery?
Lewis L. Wall, MD, DPhil
Full text | PDF Does a higher dosage of oxytocin raise the risk of rupture in VBAC candidates?
Clarissa A. Bonanno, MD; Lynn L. Simpson, MD
Full text | PDF
Back to top
|
